A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis

Trial Profile

A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs LME 636 (Primary) ; Dexamethasone
  • Indications Anterior uveitis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 04 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 15 Mar 2016 Planned End Date changed from 1 Apr 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
    • 15 Mar 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top